scholarly journals Health Care Costs attributable to Hospital-diagnosed Back Pain: A Longitudinal Register-based Study of the Danish Population

10.36469/9872 ◽  
2014 ◽  
Vol 1 (3) ◽  
pp. 266-275 ◽  
Author(s):  
Rikke Søgaard ◽  
Jan Sørensen
Keyword(s):  
Health Care ◽  
Back Pain ◽  
Health Care Costs ◽  
Reference Values ◽  
Service Use ◽  
Hospital Admissions ◽  
Chronic Back Pain ◽  
Disease Stage ◽  
Absolute Difference ◽  
Care Costs

Background: Back pain is one of most frequent musculoskeletal conditions with enormous impact to health care systems and society. Analytical studies that guide the management of this disease are strongly needed, but there is a lack of cost estimates for the attributable cost of severe or chronic back pain in particular. Objective: The objective of this study was to estimate the health care costs attributable to hospitaldiagnosed back pain across strata of age-, gender- and diagnostic entity. Methods: All adult Danes (N=4.3 million) were included in this longitudinal, controlled register-based study. One-year prevalence was defined according to a previously published and validated algorithm, which was applied to the Danish national patient registry. Data from other relevant health service use registries was appended along with data from the national cause of death registry in order to calculate cost rates per life year (2011 price year). The attributable health care cost was defined as the absolute difference in cost rates between individuals with versus individuals without hospital-diagnosed back pain, whereas the ratio between the two groups was used for the reporting of reference values. Results: The health care costs attributable to hospital-diagnosed back pain were estimated at Danish Crowns (DKK) 22,700 per year for the youngest age strata (16-24 years) and increased up to DKK 72,700 per year for the oldest age strata of males (>85 years). Hospital admissions and outpatient visits accounted for the majority of these costs. The ratio of health care costs for individuals with versus individuals without the condition ranged from less than 1 to almost 6, depending on the type of service use, age and gender. Conclusion: At the disease stage where back pain leads to contact with specialised health care, diseased individuals appear to use on average three times more health care than non-diseased individuals. This study provides detailed reference values, which can be used to inform health economic models.

scholarly journals Analgesic Usage for Low Back Pain: Impact on Health Care Costs and Service Use

Spine ◽  
2005 ◽  
Vol 30 (9) ◽  
pp. 1075-1081 ◽  
Author(s):  
Molly T. Vogt ◽  
C Kent Kwoh ◽  
Doris K. Cope ◽  
Thaddeus A. Osial ◽  
Michael Culyba ◽  
...  
Keyword(s):  
Health Care ◽  
Low Back Pain ◽  
Back Pain ◽  
Health Care Costs ◽  
Service Use ◽  
Low Back ◽  
Care Costs

scholarly journals The impact of specialised treatment of low back pain on health care costs and productivity in a nationwide cohort

2022 ◽  
Vol 43 ◽  
pp. 101247
Author(s):  
Stian Solumsmoen ◽  
Gry Poulsen ◽  
Jakob Kjellberg ◽  
Mads Melbye ◽  
Tina Nørgaard Munch
Keyword(s):  
Health Care ◽  
Low Back Pain ◽  
Back Pain ◽  
Health Care Costs ◽  
Low Back ◽  
The Impact ◽  
Care Costs

scholarly journals Health Care Costs Associated to Type of Feeding in the First Year of Life

2020 ◽  
Vol 17 (13) ◽  
pp. 4719
Author(s):  
Carolina Lechosa-Muñiz ◽  
María Paz-Zulueta ◽  
María Sáez de Adana Herrero ◽  
Elsa Cornejo del Rio ◽  
Sonia Mateo Sota ◽  
...  
Keyword(s):  
Primary Care ◽  
Health Care ◽  
Infectious Diseases ◽  
Emergency Room ◽  
Health Care Costs ◽  
Medical Records ◽  
Hospital Admissions ◽  
First Year ◽  
First Year Of Life ◽  
Care Costs

Background: Breastfeeding is associated with lower risk of infectious diseases, leading to fewer hospital admissions and pediatrician consultations. It is cost saving for the health care system, however, it is not usually estimated from actual cohorts but via simulation studies. Methods: A cohort of 970 children was followed-up for twelve months. Data on mother characteristics, pregnancy, delivery and neonate characteristics were obtained from medical records. The type of neonate feeding at discharge, 2, 4, 6, 9 and 12 months of life was reported by the mothers. Infectious diseases diagnosed in the first year of life, hospital admissions, primary care and emergency room consultations and drug treatments were obtained from neonate medical records. Health care costs were attributed using public prices and All Patients Refined–Diagnosis Related Groups (APR–DRG) classification. Results: Health care costs in the first year of life were higher in children artificially fed than in those breastfed (1339.5€, 95% confidence interval (CI): 903.0–1775.0 for artificially fed vs. 443.5€, 95% CI: 193.7–694.0 for breastfed). The breakdown of costs also shows differences in primary care consultations (295.7€ for formula fed children vs. 197.9€ for breastfed children), emergency room consultations (260.1€ for artificially fed children vs. 196.2€ for breastfed children) and hospital admissions (791.6€ for artificially fed children vs. 86.9€ for breastfed children). Conclusions: Children artificially fed brought about more health care costs related to infectious diseases than those exclusively breastfed or mixed breastfed. Excess costs were caused in hospital admissions, primary care consultations, emergency room consultations and drug consumption.

scholarly journals How Much Do Mental Health and Substance Use/Addiction Affect Use of General Medical Services? Extent of Use, Reason for Use, and Associated Costs

2016 ◽  
Vol 62 (1) ◽  
pp. 48-56 ◽  
Author(s):  
Kathryn Graham ◽  
Joyce Cheng ◽  
Sharon Bernards ◽  
Samantha Wells ◽  
Jürgen Rehm ◽  
...  
Keyword(s):  
Mental Health ◽  
Primary Care ◽  
Health Care ◽  
Substance Use ◽  
Health Care Costs ◽  
Emergency Departments ◽  
Primary Care Physicians ◽  
Service Use ◽  
Cross Sectional ◽  
Care Costs

Objective: To measure service use and costs associated with health care for patients with mental health (MH) and substance use/addiction (SA) problems. Methods: A 5-year cross-sectional study (2007-2012) of administrative health care data was conducted (average annual sample size = 123,235 adults aged >18 years who had a valid Ontario health care number and used at least 1 service during the year; 55% female). We assessed average annual use of primary care, emergency departments and hospitals, and overall health care costs for patients identified as having MH only, SA only, co-occurring MH and SA problems (MH+SA), and no MH and/or SA (MH/SA) problems. Total visits/admissions and total non-MH/SA visits (i.e., excluding MH/SA visits) were regressed separately on MH, SA, and MH+SA cases compared to non-MH/SA cases using the 2011-2012 sample ( N = 123,331), controlling for age and sex. Results: Compared to non-MH/SA patients, MH/SA patients were significantly ( P < 0.001) more likely to visit primary care physicians (1.82 times as many visits for MH-only patients, 4.24 for SA, and 5.59 for MH+SA), use emergency departments (odds, 1.53 [MH], 3.79 [SA], 5.94 [MH+SA]), and be hospitalized (odds, 1.59 [MH], 4.10 [SA], 7.82 [MH+SA]). MH/SA patients were also significantly more likely than non-MH/SA patients to have non-MH/SA-related visits and accounted for 20% of the sample but over 30% of health care costs. Conclusions: MH and SA are core issues for all health care settings. MH/SA patients use more services overall and for non-MH/SA issues, with especially high use and costs for MH+SA patients.

Direct health care costs of hospital admissions due to adverse events in the Netherlands

2014 ◽  
Vol 24 (6) ◽  
pp. 1028-1033 ◽  
Author(s):  
Fabienne J. H. Magdelijns ◽  
Patricia M. Stassen ◽  
Coen D. A. Stehouwer ◽  
Evelien Pijpers
Keyword(s):  
Health Care ◽  
The Netherlands ◽  
Adverse Events ◽  
Health Care Costs ◽  
Hospital Admissions ◽  
Care Costs

scholarly journals EX1 The Effects of Polypharmacy on Health Care Costs and Hospital Admissions in Thai Elderly Population: Multivariate Two-Part Models

2012 ◽  
Vol 15 (7) ◽  
pp. A607
Author(s):  
R. Sruamsiri ◽  
N. Jeanpeerapong ◽  
K. Jampachaisri ◽  
N. Chaiyakunapruk
Keyword(s):  
Health Care ◽  
Health Care Costs ◽  
Elderly Population ◽  
Hospital Admissions ◽  
Care Costs

scholarly journals Healthcare utilisation after discharge in patients admitted with gout in Western Australia

2021 ◽  
Author(s):  
Erin Kelty ◽  
Philip Robinson ◽  
Catherine Hill ◽  
Johannes Nossent ◽  
Warren Raymond ◽  
...  
Keyword(s):  
Health Care ◽  
Health Service ◽  
Health Care Costs ◽  
Linear Models ◽  
Hospital Admissions ◽  
Healthcare Utilisation ◽  
Health Service Utilisation ◽  
Service Utilisation ◽  
Median Cost ◽  
Care Costs

Abstract Objectives Evidence suggests that gout is associated with high health care costs and that many inpatient admissions are preventable. Understanding the drivers of health care costs in patients with gout will allow more targeted intervention. The objective was to examine factors associated with high health service utilisation and costs in patients admitted to hospital with gout. Methods Hospital and emergency department data was obtained for patients who had been admitted to hospital with a diagnosis of gout for the first time between 2002 and 2009. The total number, cost and potentially preventable events for the follow-up period was calculated for up to five years post the initial gout hospitalisation. The association between patient characteristics with health service utilisation and health care costs was examined using generalised linear models. Results The cohort included 4,379 individuals, that had 22,222 ED attendances (median cost: $1,826 per patient, IQR: $433 - $4,414), and 58,920 hospital admissions (median cost: $25,009 per patient, IQR: $6,844 - $60,535). Gout was not a primary driver of ED attendances or hospitalisations. A history of smoking and comorbidities including cardiovascular disease, diabetes and mental health disorders were associated with an increase health service utilisation and costs. Conclusion The presence of comorbidities play an important role the risk of health service utilization in people with gout and represents an opportunity to both improve the health-related outcomes for these patients and reduce re-presentations and associated health care costs for the health care system.

Abstract 124: The Effect of Renal Impairment on The Venous Thromboembolism Recurrence and Major Bleeding Risk and Total Health Care Costs in Patients With Acute Venous Thromboembolism

2015 ◽  
Vol 8 (suppl_2) ◽  
Author(s):  
Jennifer Cai ◽  
Jackie Kwong ◽  
Ron Preblick ◽  
Qiaoyi Zhang
Keyword(s):  
Health Care ◽  
Venous Thromboembolism ◽  
Renal Impairment ◽  
Health Care Costs ◽  
Anticoagulant Therapy ◽  
Major Bleeding ◽  
Index Date ◽  
Disease Stage ◽  
Care Costs

Background: Renal impairment could be a risk factor for venous thromboembolism (VTE) recurrence and anticoagulation related bleeding in VTE patients. The objective of this study was to assess the effect of renal impairment on the risk of VTE recurrence, major bleeding and total health care costs in patients with acute VTE. Methods: In this retrospective analysis of IMS PharMetrics Plus TM claims database, patients (≥18 years old) who had ≥ 1 inpatient or ≥ 2 outpatient VTE claims during January 2010-December 2013 (the index period) were identified. Patients who had continuous enrollment eligibility for at least 12 months before (baseline) and 12 months after (follow-up) the index date (first VTE claim) and had no VTE diagnosis and anticoagulant treatment during baseline period were included. Patients who required dialysis or had end stage renal disease were excluded. VTE patients with chronic kidney disease (stage I-IV or equivalent) during baseline based on ICD- 9 diagnosis codes were compared with those without renal impairment. Recurrent VTE was identified by inpatient or emergency department claims associated with VTE diagnosis after hospital discharge of the index VTE event or 7 days after index date for patients with index VTE events treated in the outpatient setting during the follow-up period. Major bleeding events were identified by inpatient claims with a bleeding diagnosis that occurred after an anticoagulant prescription fill among patients receiving anticoagulant therapy. Cox proportional hazards models adjusted for age, gender, index VTE type, health insurance type, outpatient anticoagulant therapy use, and baseline comorbidities was used to assess the risk of VTE recurrence and anticoagulation related major bleeding. Generalized linear model with gamma distribution and log link was used to evaluate the total health care costs (inclusive of medical and pharmacy costs) over the 1-year follow-up period adjusting for the same baseline characteristics. Results: Of 20,873 eligible VTE patients (median age 57 years; 50% female), 238 had diagnosed renal impairment. Compared with patients without renal impairment, patients with renal impairment had higher rates for VTE recurrence (24% vs. 18%; adjusted hazard ratio (HR) = 1.32, 95% CI 1.06-1.63, p<0.01), and post anticoagulation major bleeding (4% vs 1%; HR=1.75, 95% CI 1.01-3.03, p=0.046). Patients with renal impairment had higher adjusted mean total health care costs ($41,283 vs. $30,757, p<0.01) than patients without renal impairment. Conclusion: VTE patients with renal impairment had higher risk for VTE recurrence and major bleeding associated with anticoagulant therapy, resulting in increased utilization of health care resources than VTE patients without renal impairment. Sponsorship: This research was funded by Daiichi Sankyo Inc, Parsippany, NJ.

Sign in / Sign up

Export Citation Format

Share Document